The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,086.00
Bid: 12,086.00
Ask: 12,090.00
Change: 36.00 (0.30%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,124.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: JPMorgan Raises Man Group And Sanne

Thu, 10th Dec 2020 10:16

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

----------

FTSE 100

----------

BERENBERG RAISES CRODA INTERNATIONAL TO 'BUY' ('HOLD') - TARGET 7,200 (6,000) PENCE

----------

MORGAN STANLEY CUTS AVAST PRICE TARGET TO 610 (650) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES VODAFONE PRICE TARGET TO 205 (200) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES RIO TINTO PRICE TARGET TO 5,200 (4,290) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES GLENCORE PRICE TARGET TO 274 (215) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES EVRAZ PRICE TARGET TO 430 (410) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES BHP GROUP PRICE TARGET TO 1,960 (1,680) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES ANTOFAGASTA TARGET TO 1,305 (1,030) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES ANGLO AMERICAN TARGET TO 2,780 (2,280) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES SAGE GROUP TO 'EQUAL-WEIGHT' ('UNDERWEIGHT') - TARGET 610 PENCE

----------

JPMORGAN RAISES DS SMITH PRICE TARGET TO 408 (340) PENCE - 'OVERWEIGHT'

----------

DEUTSCHE BANK RAISES ASHTEAD GROUP PRICE TARGET TO 3,000 (2,150) PENCE - 'HOLD'

----------

BERENBERG RAISES POLYMETAL PRICE TARGET TO 2,580 (2,560) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES RIO TINTO PRICE TARGET TO 5,645 (4,685) PENCE - 'NEUTRAL'

----------

GOLDMAN RAISES BHP GROUP PRICE TARGET TO 2,360 (2,020) PENCE - 'BUY'

----------

JPMORGAN RAISES STANDARD LIFE ABERDEEN TARGET TO 315 (270) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES SCHRODERS PRICE TARGET TO 3,175 (2,800) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES INTERMEDIATE CAPITAL TARGET TO 2,000 (1,950) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS HARGREAVES LANSDOWN TARGET TO 1,390 (1,470) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS BUNZL TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 2,800 PENCE

----------

JEFFERIES RAISES ASTRAZENECA PRICE TARGET TO 8,500 (8,100) PENCE - 'HOLD'

----------

FTSE 250

----------

JPMORGAN RAISES SANNE GROUP TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 670 PENCE

----------

JPMORGAN RAISES MAN GROUP TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 150 (140) PENCE

----------

UBS RAISES VICTREX PRICE TARGET TO 1,750 (1,625) PENCE - 'SELL'

----------

MORGAN STANLEY CUTS CENTAMIN PRICE TARGET TO 125 (130) PENCE - 'EQUAL-WEIGHT'

----------

JPMORGAN RAISES INCHCAPE PRICE TARGET TO 708 (645) PENCE - 'OVERWEIGHT'

----------

BERENBERG CUTS WORKSPACE GROUP TO 'SELL' ('HOLD') - TARGET 670 (590) PENCE

----------

BARCLAYS RAISES VICTREX TO 'EQUAL WEIGHT' ('UNDERWEIGHT') - TARGET 1,980 (1,710) PENCE

----------

BARCLAYS CUTS SERCO GROUP PRICE TARGET TO 150 (165) PENCE - 'OVERWEIGHT'

----------

GOLDMAN RAISES BABCOCK INTERNATIONAL TARGET TO 290 (255) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES QUILTER PRICE TARGET TO 180 (170) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES JUPITER FUND PRICE TARGET TO 310 (300) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ASHMORE GROUP PRICE TARGET TO 385 (360) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES HOWDEN JOINERY GROUP TARGET TO 677 (641) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS SERCO GROUP PRICE TARGET TO 170 (180) PENCE - 'OVERWEIGHT'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG RAISES CERES POWER PRICE TARGET TO 1220 (1060) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES STAGECOACH PRICE TARGET TO 86 (72) PENCE - 'BUY'

----------

BERENBERG CUTS PETRA DIAMONDS PRICE TARGET TO 2 (3) PENCE - 'HOLD'

----------

BERENBERG RAISES GRIFFIN MINING PRICE TARGET TO 115 (105) PENCE - 'BUY'

----------

BERENBERG RAISES GEM DIAMONDS PRICE TARGET TO 51 (43) PENCE - 'BUY'

----------

BERENBERG RAISES CENTRAL ASIA METALS PRICE TARGET TO 250 (234) PENCE - 'BUY'

----------

BERENBERG CUTS ANGLO PACIFIC GROUP PRICE TARGET TO 140 (150) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.